

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.14564368 |
| 2 | muscle filament sliding (GO:0030049) | 6.14564368 |
| 3 | regulation of skeletal muscle contraction (GO:0014819) | 6.08485824 |
| 4 | actin-mediated cell contraction (GO:0070252) | 4.96416049 |
| 5 | sarcomere organization (GO:0045214) | 4.96032049 |
| 6 | plasma membrane repair (GO:0001778) | 4.75767797 |
| 7 | protein maturation by protein folding (GO:0022417) | 4.66523403 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.38125535 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 4.25337479 |
| 10 | pinocytosis (GO:0006907) | 4.04469035 |
| 11 | skeletal muscle contraction (GO:0003009) | 3.90617816 |
| 12 | myofibril assembly (GO:0030239) | 3.83928430 |
| 13 | actin filament-based movement (GO:0030048) | 3.74976080 |
| 14 | cardiac myofibril assembly (GO:0055003) | 3.66904600 |
| 15 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.64002015 |
| 16 | regulation of sequestering of triglyceride (GO:0010889) | 3.54010333 |
| 17 | apoptotic cell clearance (GO:0043277) | 3.48199452 |
| 18 | membrane raft organization (GO:0031579) | 3.41993331 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.37023248 |
| 20 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.33422892 |
| 21 | skeletal muscle adaptation (GO:0043501) | 3.31041376 |
| 22 | oxaloacetate metabolic process (GO:0006107) | 3.30843928 |
| 23 | carnitine shuttle (GO:0006853) | 3.29829610 |
| 24 | NADH metabolic process (GO:0006734) | 3.29699163 |
| 25 | actomyosin structure organization (GO:0031032) | 3.29133625 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.25826613 |
| 27 | Golgi transport vesicle coating (GO:0048200) | 3.25826613 |
| 28 | protein localization to endosome (GO:0036010) | 3.25465559 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.24355767 |
| 30 | UV protection (GO:0009650) | 3.22132757 |
| 31 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.21922843 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 3.21405318 |
| 33 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.18757089 |
| 34 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.18536393 |
| 35 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.17731686 |
| 36 | valine metabolic process (GO:0006573) | 3.16636796 |
| 37 | pentose-phosphate shunt (GO:0006098) | 3.14829048 |
| 38 | NIK/NF-kappaB signaling (GO:0038061) | 3.14782980 |
| 39 | creatine metabolic process (GO:0006600) | 3.13991021 |
| 40 | fibril organization (GO:0097435) | 3.12813360 |
| 41 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.07173731 |
| 42 | skeletal muscle fiber development (GO:0048741) | 3.03165609 |
| 43 | extracellular fibril organization (GO:0043206) | 3.01429772 |
| 44 | tricarboxylic acid metabolic process (GO:0072350) | 3.00106250 |
| 45 | striated muscle contraction (GO:0006941) | 2.98323224 |
| 46 | regulation of fatty acid oxidation (GO:0046320) | 2.97741386 |
| 47 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.96141678 |
| 48 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.95831545 |
| 49 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.92275194 |
| 50 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.90205769 |
| 51 | surfactant homeostasis (GO:0043129) | 2.89643601 |
| 52 | basement membrane organization (GO:0071711) | 2.88720850 |
| 53 | epithelial cell-cell adhesion (GO:0090136) | 2.87969915 |
| 54 | protein hydroxylation (GO:0018126) | 2.86523619 |
| 55 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.86272047 |
| 56 | hyaluronan catabolic process (GO:0030214) | 2.86242942 |
| 57 | positive regulation of myotube differentiation (GO:0010831) | 2.84788337 |
| 58 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.84067488 |
| 59 | keratan sulfate catabolic process (GO:0042340) | 2.83350700 |
| 60 | glucose catabolic process (GO:0006007) | 2.83059095 |
| 61 | regulation of cholesterol storage (GO:0010885) | 2.82961772 |
| 62 | barbed-end actin filament capping (GO:0051016) | 2.81532240 |
| 63 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.81500977 |
| 64 | proline biosynthetic process (GO:0006561) | 2.80548872 |
| 65 | protein heterotrimerization (GO:0070208) | 2.79600718 |
| 66 | lipid particle organization (GO:0034389) | 2.78992091 |
| 67 | regulation of tight junction assembly (GO:2000810) | 2.77861840 |
| 68 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.76788988 |
| 69 | DNA unwinding involved in DNA replication (GO:0006268) | 2.76352257 |
| 70 | cytidine deamination (GO:0009972) | 2.74791789 |
| 71 | cytidine metabolic process (GO:0046087) | 2.74791789 |
| 72 | cytidine catabolic process (GO:0006216) | 2.74791789 |
| 73 | cardiac muscle cell development (GO:0055013) | 2.74118919 |
| 74 | purine nucleotide salvage (GO:0032261) | 2.73563874 |
| 75 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.73324666 |
| 76 | heart trabecula formation (GO:0060347) | 2.71307569 |
| 77 | cardiac muscle contraction (GO:0060048) | 2.70519765 |
| 78 | regulation of relaxation of muscle (GO:1901077) | 2.68089750 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 2.67639989 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.67123275 |
| 81 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.67123275 |
| 82 | muscle contraction (GO:0006936) | 2.67017941 |
| 83 | skin morphogenesis (GO:0043589) | 2.66876396 |
| 84 | protein retention in ER lumen (GO:0006621) | 2.66739848 |
| 85 | biotin metabolic process (GO:0006768) | 2.65282275 |
| 86 | angiogenesis involved in wound healing (GO:0060055) | 2.63970211 |
| 87 | hemidesmosome assembly (GO:0031581) | 2.63951357 |
| 88 | response to muscle activity (GO:0014850) | 2.63543664 |
| 89 | fatty acid beta-oxidation (GO:0006635) | 2.63315092 |
| 90 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.63192356 |
| 91 | apoptotic process involved in morphogenesis (GO:0060561) | 2.62703081 |
| 92 | cardiac cell development (GO:0055006) | 2.62676230 |
| 93 | negative regulation of cell size (GO:0045792) | 2.62610052 |
| 94 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.62349729 |
| 95 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.61321047 |
| 96 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59487664 |
| 97 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.59300917 |
| 98 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59196180 |
| 99 | mitotic nuclear envelope reassembly (GO:0007084) | 2.58188306 |
| 100 | nuclear envelope reassembly (GO:0031468) | 2.58188306 |
| 101 | endothelial cell chemotaxis (GO:0035767) | 2.57832993 |
| 102 | phagocytosis, recognition (GO:0006910) | 2.57774841 |
| 103 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.57661014 |
| 104 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.56942236 |
| 105 | stress fiber assembly (GO:0043149) | 2.55796487 |
| 106 | lymph vessel development (GO:0001945) | 2.55228845 |
| 107 | cell-substrate junction assembly (GO:0007044) | 2.55071841 |
| 108 | modulation by symbiont of host cellular process (GO:0044068) | 2.54836154 |
| 109 | negative regulation of stress fiber assembly (GO:0051497) | 2.53947663 |
| 110 | focal adhesion assembly (GO:0048041) | 2.52183537 |
| 111 | cell-substrate adherens junction assembly (GO:0007045) | 2.52183537 |
| 112 | regulation of p38MAPK cascade (GO:1900744) | 2.52015061 |
| 113 | adherens junction assembly (GO:0034333) | 2.50094421 |
| 114 | cell migration involved in heart development (GO:0060973) | 2.48899855 |
| 115 | NADPH regeneration (GO:0006740) | 2.48842871 |
| 116 | cellular response to zinc ion (GO:0071294) | 2.47848234 |
| 117 | muscle system process (GO:0003012) | 2.47546626 |
| 118 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.45851657 |
| 119 | negative regulation of heart growth (GO:0061117) | 2.45851657 |
| 120 | mitotic chromosome condensation (GO:0007076) | 2.45608800 |
| 121 | desmosome organization (GO:0002934) | 2.45370553 |
| 122 | glomerular visceral epithelial cell development (GO:0072015) | 2.45211460 |
| 123 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.44623459 |
| 124 | glycogen biosynthetic process (GO:0005978) | 2.44420100 |
| 125 | glucan biosynthetic process (GO:0009250) | 2.44420100 |
| 126 | positive regulation of fatty acid oxidation (GO:0046321) | 2.43547383 |
| 127 | myotube cell development (GO:0014904) | 2.43309676 |
| 128 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.42952749 |
| 129 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.42320891 |
| 130 | glomerular basement membrane development (GO:0032836) | 2.42143195 |
| 131 | peptidyl-proline hydroxylation (GO:0019511) | 2.41820788 |
| 132 | positive regulation of nuclease activity (GO:0032075) | 2.41643020 |
| 133 | heart process (GO:0003015) | 2.41625178 |
| 134 | heart contraction (GO:0060047) | 2.41625178 |
| 135 | regulation of superoxide anion generation (GO:0032928) | 2.41224593 |
| 136 | muscle fiber development (GO:0048747) | 2.40803277 |
| 137 | negative regulation of necroptotic process (GO:0060546) | 2.40226681 |
| 138 | regulation of extracellular matrix disassembly (GO:0010715) | 2.39664855 |
| 139 | regulation of early endosome to late endosome transport (GO:2000641) | 2.39025962 |
| 140 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34068693 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.33046085 |
| 142 | modulation by virus of host process (GO:0019054) | 2.32532267 |
| 143 | embryo implantation (GO:0007566) | 2.32246025 |
| 144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.31989766 |
| 145 | regulation of metalloenzyme activity (GO:0048552) | 2.31635557 |
| 146 | regulation of necrotic cell death (GO:0010939) | 2.30939919 |
| 147 | atrioventricular valve morphogenesis (GO:0003181) | 2.30637553 |
| 148 | GDP-mannose metabolic process (GO:0019673) | 2.30345839 |
| 149 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.29452215 |
| 150 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.29171857 |
| 151 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.26878013 |
| 152 | adhesion of symbiont to host (GO:0044406) | 2.26593410 |
| 153 | mature B cell differentiation involved in immune response (GO:0002313) | 2.26354519 |
| 154 | pyrimidine-containing compound salvage (GO:0008655) | 2.25383898 |
| 155 | pyrimidine nucleoside salvage (GO:0043097) | 2.25383898 |
| 156 | regulation of defense response to virus by virus (GO:0050690) | 2.23907907 |
| 157 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.23313811 |
| 158 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.21499331 |
| 159 | modulation by virus of host morphology or physiology (GO:0019048) | 2.21052532 |
| 160 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.19732948 |
| 161 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.19615164 |
| 162 | maternal placenta development (GO:0001893) | 2.18789021 |
| 163 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.18482798 |
| 164 | response to progesterone (GO:0032570) | 2.17692853 |
| 165 | response to thyroid hormone (GO:0097066) | 2.17478481 |
| 166 | regulation of nuclease activity (GO:0032069) | 2.17009900 |
| 167 | virion attachment to host cell (GO:0019062) | 2.15694711 |
| 168 | adhesion of symbiont to host cell (GO:0044650) | 2.15694711 |
| 169 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.15100420 |
| 170 | regulation of necroptotic process (GO:0060544) | 2.14765660 |
| 171 | positive regulation of odontogenesis (GO:0042482) | 2.14374454 |
| 172 | mannose metabolic process (GO:0006013) | 2.13242744 |
| 173 | cellular hyperosmotic response (GO:0071474) | 2.13225849 |
| 174 | cortical actin cytoskeleton organization (GO:0030866) | 2.12907925 |
| 175 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.07754406 |
| 176 | positive regulation of lamellipodium organization (GO:1902745) | 2.07680527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.82908830 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.87045051 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.83253546 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.63522021 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.25092519 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.02777680 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.50651066 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.50057213 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48287508 |
| 10 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.47035514 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.28327990 |
| 12 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.18379527 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16822560 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16467989 |
| 15 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.00674148 |
| 16 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.98785839 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97219668 |
| 18 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.93836086 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.93836086 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.92843611 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.91802458 |
| 22 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.78720626 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.77726878 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72313006 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.72263345 |
| 26 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.71821839 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.70419129 |
| 28 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.69046675 |
| 29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.68501293 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65047066 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64358350 |
| 32 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62853848 |
| 33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61440437 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61410908 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59725153 |
| 36 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.59302422 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.58982417 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56890787 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.52385384 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51418221 |
| 41 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47729456 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.46653537 |
| 43 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44559111 |
| 44 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.44160116 |
| 45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43422235 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42693300 |
| 47 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42600006 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42372523 |
| 49 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34453941 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34341775 |
| 51 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.32701243 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32159869 |
| 53 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.32131731 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32005053 |
| 55 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31917724 |
| 56 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31531657 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.30678953 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29925365 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.29694937 |
| 60 | * MAF_26560356_Chip-Seq_TH1_Human | 1.29054059 |
| 61 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.28486330 |
| 62 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.28316905 |
| 63 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28267254 |
| 64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27805762 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.26446439 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.25840053 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25589498 |
| 68 | * MAF_26560356_Chip-Seq_TH2_Human | 1.24467039 |
| 69 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.23953010 |
| 70 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.23453600 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22633114 |
| 72 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22313137 |
| 73 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22242458 |
| 74 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21776709 |
| 75 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.21408857 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20378863 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20167100 |
| 78 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18056692 |
| 79 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18017592 |
| 80 | CJUN_26792858_Chip-Seq_BT549_Human | 1.17338800 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.16808072 |
| 82 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16379351 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16117333 |
| 84 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.15350918 |
| 85 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13955044 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.13857428 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13571905 |
| 88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12775284 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11385025 |
| 90 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.11329781 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11228325 |
| 92 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10914139 |
| 93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.10623527 |
| 94 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10456539 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09893026 |
| 96 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09754779 |
| 97 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.08411948 |
| 98 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.08277733 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08196186 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07685512 |
| 101 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07637180 |
| 102 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07396141 |
| 103 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06258198 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05980072 |
| 105 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05895860 |
| 106 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.05621165 |
| 107 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05260539 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04946768 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.04623154 |
| 110 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03980582 |
| 111 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03554596 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03488820 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02966332 |
| 114 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02752125 |
| 115 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02223092 |
| 116 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01399023 |
| 117 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.01291113 |
| 118 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01229105 |
| 119 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01189599 |
| 120 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01113203 |
| 121 | P68_20966046_ChIP-Seq_HELA_Human | 1.01105933 |
| 122 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01082616 |
| 123 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.00921438 |
| 124 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00771525 |
| 125 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00749281 |
| 126 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.00682102 |
| 127 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99299067 |
| 128 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99086983 |
| 129 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97695841 |
| 130 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97695841 |
| 131 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.96843810 |
| 132 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95893263 |
| 133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95875894 |
| 134 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95415258 |
| 135 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94884177 |
| 136 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93674270 |
| 137 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.92425056 |
| 138 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92117603 |
| 139 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91132210 |
| 140 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90576473 |
| 141 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90534867 |
| 142 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89099319 |
| 143 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88928716 |
| 144 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88838137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000749_muscle_degeneration | 3.79461904 |
| 2 | MP0000751_myopathy | 3.70771931 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.57655256 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.17718513 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.13668932 |
| 6 | MP0003646_muscle_fatigue | 3.03257475 |
| 7 | MP0005275_abnormal_skin_tensile | 2.86313592 |
| 8 | MP0000750_abnormal_muscle_regeneration | 2.65024740 |
| 9 | MP0004084_abnormal_cardiac_muscle | 2.56540873 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.51660426 |
| 11 | MP0005451_abnormal_body_composition | 2.46591384 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.42114868 |
| 13 | MP0003279_aneurysm | 2.33529101 |
| 14 | MP0004145_abnormal_muscle_electrophysio | 2.31332075 |
| 15 | MP0004130_abnormal_muscle_cell | 2.27651023 |
| 16 | MP0004087_abnormal_muscle_fiber | 2.25209010 |
| 17 | MP0002106_abnormal_muscle_physiology | 2.00096836 |
| 18 | MP0005670_abnormal_white_adipose | 1.98143186 |
| 19 | MP0005330_cardiomyopathy | 1.96821979 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.95033552 |
| 21 | MP0000759_abnormal_skeletal_muscle | 1.93825545 |
| 22 | MP0000747_muscle_weakness | 1.93486493 |
| 23 | MP0004272_abnormal_basement_membrane | 1.85375535 |
| 24 | MP0002269_muscular_atrophy | 1.83830712 |
| 25 | MP0005620_abnormal_muscle_contractility | 1.82431000 |
| 26 | MP0000013_abnormal_adipose_tissue | 1.75569306 |
| 27 | MP0000343_altered_response_to | 1.74518183 |
| 28 | MP0006054_spinal_hemorrhage | 1.73747138 |
| 29 | MP0001879_abnormal_lymphatic_vessel | 1.72375351 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.70912508 |
| 31 | MP0005369_muscle_phenotype | 1.67471070 |
| 32 | MP0003828_pulmonary_edema | 1.67053446 |
| 33 | MP0008260_abnormal_autophagy | 1.66482678 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.66271732 |
| 35 | MP0001958_emphysema | 1.66098071 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.65996442 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.57330559 |
| 38 | MP0002972_abnormal_cardiac_muscle | 1.57049187 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.54131761 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.52672826 |
| 41 | MP0009278_abnormal_bone_marrow | 1.52498344 |
| 42 | MP0004233_abnormal_muscle_weight | 1.47798071 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.46757335 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.46757335 |
| 45 | MP0006138_congestive_heart_failure | 1.44885799 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.44863942 |
| 47 | MP0000733_abnormal_muscle_development | 1.44188393 |
| 48 | MP0003303_peritoneal_inflammation | 1.43466759 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.39354115 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.38414397 |
| 51 | MP0005375_adipose_tissue_phenotype | 1.34453156 |
| 52 | * MP0003763_abnormal_thymus_physiology | 1.34265302 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.31138442 |
| 54 | MP0001849_ear_inflammation | 1.28856875 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.28734789 |
| 56 | MP0009840_abnormal_foam_cell | 1.28396400 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.23127351 |
| 58 | MP0005165_increased_susceptibility_to | 1.22424693 |
| 59 | MP0005025_abnormal_response_to | 1.19848179 |
| 60 | MP0005023_abnormal_wound_healing | 1.17827977 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.14782359 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.13824104 |
| 63 | MP0002108_abnormal_muscle_morphology | 1.13482723 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.11366533 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.10577098 |
| 66 | MP0002419_abnormal_innate_immunity | 1.09673594 |
| 67 | MP0005501_abnormal_skin_physiology | 1.09442268 |
| 68 | MP0004858_abnormal_nervous_system | 1.09411641 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.09167892 |
| 70 | MP0003950_abnormal_plasma_membrane | 1.09048174 |
| 71 | MP0003724_increased_susceptibility_to | 1.06581036 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.05580669 |
| 73 | MP0000767_abnormal_smooth_muscle | 1.05165757 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.05115651 |
| 75 | MP0002971_abnormal_brown_adipose | 1.03648174 |
| 76 | MP0002166_altered_tumor_susceptibility | 1.02779204 |
| 77 | MP0004484_altered_response_of | 1.02587028 |
| 78 | MP0003172_abnormal_lysosome_physiology | 1.02557812 |
| 79 | MP0004510_myositis | 1.02536189 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.02229105 |
| 81 | MP0003300_gastrointestinal_ulcer | 1.01468271 |
| 82 | MP0003436_decreased_susceptibility_to | 1.01347574 |
| 83 | MP0000678_abnormal_parathyroid_gland | 1.00822584 |
| 84 | MP0000490_abnormal_crypts_of | 0.99904461 |
| 85 | MP0002060_abnormal_skin_morphology | 0.99538568 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.99094969 |
| 87 | MP0001790_abnormal_immune_system | 0.97126217 |
| 88 | MP0005387_immune_system_phenotype | 0.97126217 |
| 89 | MP0001853_heart_inflammation | 0.95839114 |
| 90 | MP0002452_abnormal_antigen_presenting | 0.95803771 |
| 91 | MP0001348_abnormal_lacrimal_gland | 0.93399870 |
| 92 | * MP0002420_abnormal_adaptive_immunity | 0.92689338 |
| 93 | MP0002933_joint_inflammation | 0.92682906 |
| 94 | MP0002398_abnormal_bone_marrow | 0.92359622 |
| 95 | MP0005076_abnormal_cell_differentiation | 0.91760390 |
| 96 | MP0009384_cardiac_valve_regurgitation | 0.91736021 |
| 97 | * MP0001819_abnormal_immune_cell | 0.91463870 |
| 98 | MP0001873_stomach_inflammation | 0.91423015 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.91336853 |
| 100 | MP0001545_abnormal_hematopoietic_system | 0.91336853 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90219965 |
| 102 | MP0002723_abnormal_immune_serum | 0.89728278 |
| 103 | MP0010030_abnormal_orbit_morphology | 0.87098837 |
| 104 | MP0003448_altered_tumor_morphology | 0.86411538 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.86126663 |
| 106 | MP0002796_impaired_skin_barrier | 0.86078063 |
| 107 | MP0001851_eye_inflammation | 0.85819294 |
| 108 | MP0002429_abnormal_blood_cell | 0.85638932 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 0.84674236 |
| 110 | MP0001542_abnormal_bone_strength | 0.84564015 |
| 111 | MP0002405_respiratory_system_inflammati | 0.84094782 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.83492538 |
| 113 | MP0009785_altered_susceptibility_to | 0.83095059 |
| 114 | MP0006036_abnormal_mitochondrial_physio | 0.82393150 |
| 115 | MP0002128_abnormal_blood_circulation | 0.82285628 |
| 116 | MP0002722_abnormal_immune_system | 0.81981862 |
| 117 | MP0001800_abnormal_humoral_immune | 0.81363302 |
| 118 | MP0003045_fibrosis | 0.79430178 |
| 119 | MP0001243_abnormal_dermal_layer | 0.77916203 |
| 120 | MP0001835_abnormal_antigen_presentation | 0.77703289 |
| 121 | MP0009115_abnormal_fat_cell | 0.75965453 |
| 122 | MP0000249_abnormal_blood_vessel | 0.75803573 |
| 123 | MP0005257_abnormal_intraocular_pressure | 0.74325106 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.73334635 |
| 125 | MP0003091_abnormal_cell_migration | 0.72172084 |
| 126 | MP0000266_abnormal_heart_morphology | 0.71528284 |
| 127 | MP0005390_skeleton_phenotype | 0.69769395 |
| 128 | MP0001756_abnormal_urination | 0.69138054 |
| 129 | MP0000685_abnormal_immune_system | 0.68996496 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.68824958 |
| 131 | MP0000858_altered_metastatic_potential | 0.68783155 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.68125393 |
| 133 | MP0009643_abnormal_urine_homeostasis | 0.67772896 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.66848553 |
| 135 | MP0003075_altered_response_to | 0.65680567 |
| 136 | MP0003137_abnormal_impulse_conducting | 0.65455198 |
| 137 | MP0010352_gastrointestinal_tract_polyps | 0.63248612 |
| 138 | MP0002127_abnormal_cardiovascular_syste | 0.62988535 |
| 139 | MP0005508_abnormal_skeleton_morphology | 0.62913622 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.62486345 |
| 141 | MP0005334_abnormal_fat_pad | 0.62427260 |
| 142 | MP0001614_abnormal_blood_vessel | 0.59475187 |
| 143 | MP0004947_skin_inflammation | 0.58236233 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.58219625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type 1 muscle fiber predominance (HP:0003803) | 5.45727744 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.25632287 |
| 3 | Exercise-induced myalgia (HP:0003738) | 5.20781120 |
| 4 | Increased connective tissue (HP:0009025) | 5.03062379 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 4.92837952 |
| 6 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.89498499 |
| 7 | Muscle fiber splitting (HP:0003555) | 4.71629391 |
| 8 | Nemaline bodies (HP:0003798) | 4.33696240 |
| 9 | Myoglobinuria (HP:0002913) | 4.20790047 |
| 10 | Difficulty running (HP:0009046) | 4.05462944 |
| 11 | Distal arthrogryposis (HP:0005684) | 4.03807168 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 3.89625939 |
| 13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.81563868 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 3.78879086 |
| 15 | Myopathic facies (HP:0002058) | 3.71362692 |
| 16 | Ulnar deviation of the wrist (HP:0003049) | 3.71272812 |
| 17 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.70861067 |
| 18 | Round ear (HP:0100830) | 3.69646890 |
| 19 | Increased variability in muscle fiber diameter (HP:0003557) | 3.55211711 |
| 20 | Asymmetric septal hypertrophy (HP:0001670) | 3.53432361 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 3.52839613 |
| 22 | Protrusio acetabuli (HP:0003179) | 3.44808704 |
| 23 | EMG: myopathic abnormalities (HP:0003458) | 3.42142055 |
| 24 | Sudden death (HP:0001699) | 3.41270283 |
| 25 | Ventricular tachycardia (HP:0004756) | 3.40870300 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.34214846 |
| 27 | Difficulty climbing stairs (HP:0003551) | 3.30344265 |
| 28 | Muscle stiffness (HP:0003552) | 3.22725639 |
| 29 | Right ventricular cardiomyopathy (HP:0011663) | 3.14852495 |
| 30 | Myotonia (HP:0002486) | 3.13857829 |
| 31 | Premature rupture of membranes (HP:0001788) | 3.00904071 |
| 32 | Calcaneovalgus deformity (HP:0001848) | 3.00784320 |
| 33 | Spinal rigidity (HP:0003306) | 2.99456053 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.90983898 |
| 35 | Lipoatrophy (HP:0100578) | 2.78971793 |
| 36 | Deformed tarsal bones (HP:0008119) | 2.76835372 |
| 37 | Neck muscle weakness (HP:0000467) | 2.72039627 |
| 38 | Cerebral aneurysm (HP:0004944) | 2.69920559 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.66586256 |
| 40 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.64630548 |
| 41 | Subaortic stenosis (HP:0001682) | 2.64630548 |
| 42 | Ankle contracture (HP:0006466) | 2.63775410 |
| 43 | Slender build (HP:0001533) | 2.57481157 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.57101313 |
| 45 | Limb-girdle muscle atrophy (HP:0003797) | 2.56855548 |
| 46 | Facial diplegia (HP:0001349) | 2.55244747 |
| 47 | Absent phalangeal crease (HP:0006109) | 2.51473506 |
| 48 | Frequent falls (HP:0002359) | 2.49360594 |
| 49 | Malignant hyperthermia (HP:0002047) | 2.45993467 |
| 50 | Trismus (HP:0000211) | 2.43593391 |
| 51 | Mesangial abnormality (HP:0001966) | 2.41586040 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40033775 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40033775 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40033775 |
| 55 | Cellulitis (HP:0100658) | 2.33580753 |
| 56 | Osteolytic defects of the hand bones (HP:0009699) | 2.32488130 |
| 57 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32488130 |
| 58 | Fatigue (HP:0012378) | 2.29777244 |
| 59 | Broad metatarsal (HP:0001783) | 2.28952475 |
| 60 | Aortic aneurysm (HP:0004942) | 2.28412911 |
| 61 | Abnormality of the calcaneus (HP:0008364) | 2.27230642 |
| 62 | Scapular winging (HP:0003691) | 2.26907670 |
| 63 | Aortic dissection (HP:0002647) | 2.25700325 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.25219046 |
| 65 | Dilated cardiomyopathy (HP:0001644) | 2.21701159 |
| 66 | Axonal loss (HP:0003447) | 2.21528719 |
| 67 | Nonimmune hydrops fetalis (HP:0001790) | 2.19958379 |
| 68 | Abnormality of the Achilles tendon (HP:0005109) | 2.17354741 |
| 69 | Hyperacusis (HP:0010780) | 2.16155885 |
| 70 | Generalized muscle weakness (HP:0003324) | 2.15522511 |
| 71 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.14216840 |
| 72 | Gowers sign (HP:0003391) | 2.14205947 |
| 73 | Conjunctival hamartoma (HP:0100780) | 2.13938935 |
| 74 | Progressive muscle weakness (HP:0003323) | 2.13760388 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 2.12186892 |
| 76 | Blue sclerae (HP:0000592) | 2.10918896 |
| 77 | Ketoacidosis (HP:0001993) | 2.10883301 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.10399309 |
| 79 | Atrial fibrillation (HP:0005110) | 2.09957885 |
| 80 | Broad face (HP:0000283) | 2.08191854 |
| 81 | Polycythemia (HP:0001901) | 2.05375166 |
| 82 | Short nail (HP:0001799) | 2.05173306 |
| 83 | Hypertriglyceridemia (HP:0002155) | 2.04433382 |
| 84 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.04147554 |
| 85 | J-shaped sella turcica (HP:0002680) | 2.03868052 |
| 86 | Fragile skin (HP:0001030) | 2.03213392 |
| 87 | Palpitations (HP:0001962) | 2.02805413 |
| 88 | Glucose intolerance (HP:0000833) | 2.02574468 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.02132434 |
| 90 | Elbow flexion contracture (HP:0002987) | 1.99441977 |
| 91 | Cholecystitis (HP:0001082) | 1.98984395 |
| 92 | Abnormal gallbladder physiology (HP:0012438) | 1.98984395 |
| 93 | Generalized amyotrophy (HP:0003700) | 1.98507413 |
| 94 | Hypertensive crisis (HP:0100735) | 1.97967170 |
| 95 | Areflexia of lower limbs (HP:0002522) | 1.97847234 |
| 96 | Dilatation of the ascending aorta (HP:0005111) | 1.97256016 |
| 97 | Bulbar palsy (HP:0001283) | 1.96978318 |
| 98 | Testicular atrophy (HP:0000029) | 1.96377815 |
| 99 | Wormian bones (HP:0002645) | 1.95012649 |
| 100 | Abnormality of the neuromuscular junction (HP:0003398) | 1.93415969 |
| 101 | Fatigable weakness (HP:0003473) | 1.93415969 |
| 102 | Abnormality of macrophages (HP:0004311) | 1.92343514 |
| 103 | Primary atrial arrhythmia (HP:0001692) | 1.91234890 |
| 104 | Muscular dystrophy (HP:0003560) | 1.91026260 |
| 105 | Supraventricular arrhythmia (HP:0005115) | 1.89631214 |
| 106 | Increased cerebral lipofuscin (HP:0011813) | 1.88271362 |
| 107 | Esophageal neoplasm (HP:0100751) | 1.87927271 |
| 108 | Neoplasm of head and neck (HP:0012288) | 1.87927271 |
| 109 | Supraventricular tachycardia (HP:0004755) | 1.86689332 |
| 110 | Colitis (HP:0002583) | 1.86591419 |
| 111 | Distal upper limb amyotrophy (HP:0007149) | 1.86467327 |
| 112 | Upper limb amyotrophy (HP:0009129) | 1.86467327 |
| 113 | Biconcave vertebral bodies (HP:0004586) | 1.86197760 |
| 114 | Oligomenorrhea (HP:0000876) | 1.85566306 |
| 115 | Achilles tendon contracture (HP:0001771) | 1.85510364 |
| 116 | Increased serum ferritin (HP:0003281) | 1.85407088 |
| 117 | Dysostosis multiplex (HP:0000943) | 1.84501536 |
| 118 | Hepatosplenomegaly (HP:0001433) | 1.84091651 |
| 119 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.82634198 |
| 120 | Mucopolysacchariduria (HP:0008155) | 1.82634198 |
| 121 | Easy fatigability (HP:0003388) | 1.82159157 |
| 122 | Abnormal finger flexion creases (HP:0006143) | 1.81266769 |
| 123 | Increased density of long bones (HP:0006392) | 1.81154990 |
| 124 | Peritonitis (HP:0002586) | 1.80389104 |
| 125 | Back pain (HP:0003418) | 1.79804477 |
| 126 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77796732 |
| 127 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77796732 |
| 128 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77796732 |
| 129 | Mitral regurgitation (HP:0001653) | 1.75730253 |
| 130 | Nuclear cataract (HP:0100018) | 1.75570503 |
| 131 | Abnormality of the umbilical cord (HP:0010881) | 1.75279301 |
| 132 | Stridor (HP:0010307) | 1.75107399 |
| 133 | Growth hormone excess (HP:0000845) | 1.74738526 |
| 134 | EMG: neuropathic changes (HP:0003445) | 1.74530063 |
| 135 | Joint stiffness (HP:0001387) | 1.74334259 |
| 136 | Aneurysm (HP:0002617) | 1.73939527 |
| 137 | Gastrointestinal dysmotility (HP:0002579) | 1.73890294 |
| 138 | Shallow orbits (HP:0000586) | 1.73781030 |
| 139 | Atrophic scars (HP:0001075) | 1.72739463 |
| 140 | Amyloidosis (HP:0011034) | 1.71703353 |
| 141 | Acanthosis nigricans (HP:0000956) | 1.70893426 |
| 142 | Bladder diverticulum (HP:0000015) | 1.70489782 |
| 143 | Cervical subluxation (HP:0003308) | 1.70076770 |
| 144 | Hypoglycemic coma (HP:0001325) | 1.69912602 |
| 145 | Myocardial infarction (HP:0001658) | 1.69251352 |
| 146 | Hemorrhage of the eye (HP:0011885) | 1.68516887 |
| 147 | Limb-girdle muscle weakness (HP:0003325) | 1.68330923 |
| 148 | Emphysema (HP:0002097) | 1.67698490 |
| 149 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.67627883 |
| 150 | Long toe (HP:0010511) | 1.67080245 |
| 151 | Rough bone trabeculation (HP:0100670) | 1.66770551 |
| 152 | Gastrointestinal inflammation (HP:0004386) | 1.66490702 |
| 153 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.66217774 |
| 154 | Follicular hyperkeratosis (HP:0007502) | 1.65799580 |
| 155 | Increased IgE level (HP:0003212) | 1.65611018 |
| 156 | Eczematoid dermatitis (HP:0000976) | 1.64521952 |
| 157 | Loss of speech (HP:0002371) | 1.64504951 |
| 158 | Abnormality of the nasal mucosa (HP:0000433) | 1.64435474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 5.09307827 |
| 2 | TRIB3 | 4.77834870 |
| 3 | ERN1 | 3.68752490 |
| 4 | SMG1 | 2.89140733 |
| 5 | OBSCN | 2.82017815 |
| 6 | TESK2 | 2.78654631 |
| 7 | TGFBR2 | 2.76507939 |
| 8 | PRPF4B | 2.66708602 |
| 9 | TIE1 | 2.48639479 |
| 10 | PHKG2 | 2.37686452 |
| 11 | PHKG1 | 2.37686452 |
| 12 | PKN2 | 2.33945348 |
| 13 | BCKDK | 2.31003981 |
| 14 | MAP2K3 | 2.12403941 |
| 15 | EPHA2 | 2.11382976 |
| 16 | MYLK | 2.11325801 |
| 17 | KDR | 2.08865041 |
| 18 | ARAF | 1.95176018 |
| 19 | PIK3CG | 1.85488339 |
| 20 | ICK | 1.84209906 |
| 21 | VRK2 | 1.81844495 |
| 22 | SCYL2 | 1.80094214 |
| 23 | MOS | 1.76857210 |
| 24 | DMPK | 1.73936680 |
| 25 | NEK9 | 1.73598954 |
| 26 | TAOK2 | 1.64546866 |
| 27 | NEK1 | 1.64133613 |
| 28 | LRRK2 | 1.59848119 |
| 29 | MAP3K3 | 1.49659936 |
| 30 | STK10 | 1.49380275 |
| 31 | RIPK1 | 1.45687378 |
| 32 | TBK1 | 1.44262071 |
| 33 | SIK1 | 1.35773550 |
| 34 | PDK4 | 1.32711817 |
| 35 | PDK3 | 1.32711817 |
| 36 | PIM2 | 1.31010444 |
| 37 | MAP3K13 | 1.30534494 |
| 38 | CDK12 | 1.29432221 |
| 39 | PDK2 | 1.28062580 |
| 40 | ILK | 1.25432305 |
| 41 | PDGFRA | 1.21696501 |
| 42 | PTK6 | 1.17604460 |
| 43 | ZAP70 | 1.17214614 |
| 44 | LMTK2 | 1.12212023 |
| 45 | TRPM7 | 1.10714751 |
| 46 | EPHB1 | 1.09315087 |
| 47 | RPS6KA4 | 1.09275836 |
| 48 | MST1R | 1.04886718 |
| 49 | MAPKAPK3 | 1.04560753 |
| 50 | FGFR4 | 0.99415733 |
| 51 | PAK4 | 0.98259553 |
| 52 | EPHA3 | 0.98070553 |
| 53 | MAPK12 | 0.97299252 |
| 54 | PTK2B | 0.96223019 |
| 55 | NME2 | 0.95914063 |
| 56 | EPHB2 | 0.91625042 |
| 57 | STK24 | 0.90825145 |
| 58 | TYK2 | 0.87074284 |
| 59 | MAP3K11 | 0.83127193 |
| 60 | MAP3K14 | 0.82112704 |
| 61 | NME1 | 0.82002605 |
| 62 | MAP3K7 | 0.80711994 |
| 63 | CDC42BPA | 0.80287521 |
| 64 | JAK3 | 0.79281848 |
| 65 | CDK7 | 0.79119658 |
| 66 | TGFBR1 | 0.78025583 |
| 67 | BLK | 0.77592172 |
| 68 | KIT | 0.77284057 |
| 69 | BMX | 0.76973084 |
| 70 | FER | 0.76692725 |
| 71 | EEF2K | 0.76177772 |
| 72 | PRKD2 | 0.76076776 |
| 73 | CDK8 | 0.74519574 |
| 74 | PIK3CA | 0.72795546 |
| 75 | MAP3K10 | 0.71598435 |
| 76 | RPS6KB2 | 0.70510023 |
| 77 | MAP2K1 | 0.68169049 |
| 78 | TESK1 | 0.67564441 |
| 79 | LATS2 | 0.65985730 |
| 80 | JAK1 | 0.65817842 |
| 81 | BUB1 | 0.65760128 |
| 82 | TAOK1 | 0.64431165 |
| 83 | ROCK1 | 0.64161420 |
| 84 | MAP4K1 | 0.63971707 |
| 85 | CDK4 | 0.62991655 |
| 86 | AURKA | 0.62682240 |
| 87 | CLK1 | 0.62523817 |
| 88 | PRKD1 | 0.62367436 |
| 89 | IRAK4 | 0.62350456 |
| 90 | PAK2 | 0.61921771 |
| 91 | BRAF | 0.61905084 |
| 92 | MTOR | 0.61617236 |
| 93 | DDR2 | 0.61418606 |
| 94 | PTK2 | 0.60773528 |
| 95 | MAPKAPK2 | 0.59367601 |
| 96 | PAK1 | 0.57448557 |
| 97 | PDPK1 | 0.57308974 |
| 98 | FLT3 | 0.56243192 |
| 99 | DAPK1 | 0.53811807 |
| 100 | CSF1R | 0.51357736 |
| 101 | MAP3K1 | 0.50883427 |
| 102 | GRK6 | 0.49314955 |
| 103 | KSR2 | 0.49117750 |
| 104 | MAPK7 | 0.48967132 |
| 105 | JAK2 | 0.48493829 |
| 106 | MAP2K2 | 0.48433298 |
| 107 | MET | 0.47724714 |
| 108 | DAPK3 | 0.45625642 |
| 109 | MUSK | 0.45150210 |
| 110 | MAP3K6 | 0.44526509 |
| 111 | IRAK3 | 0.43136247 |
| 112 | PRKG2 | 0.42704331 |
| 113 | MAP3K8 | 0.42295769 |
| 114 | RET | 0.41437475 |
| 115 | GRK7 | 0.40738453 |
| 116 | RIPK4 | 0.40591972 |
| 117 | IKBKE | 0.40279580 |
| 118 | MAPK11 | 0.40265326 |
| 119 | CAMK1D | 0.40021394 |
| 120 | CDK9 | 0.37819027 |
| 121 | MAP3K5 | 0.37577530 |
| 122 | PRKCH | 0.34936858 |
| 123 | BTK | 0.34783170 |
| 124 | CCNB1 | 0.34239211 |
| 125 | SIK3 | 0.34218258 |
| 126 | MATK | 0.32988379 |
| 127 | ABL2 | 0.32941992 |
| 128 | CSK | 0.31008982 |
| 129 | LIMK1 | 0.30931600 |
| 130 | RPS6KA6 | 0.30744132 |
| 131 | RPS6KL1 | 0.29090927 |
| 132 | RPS6KC1 | 0.29090927 |
| 133 | PDGFRB | 0.28825095 |
| 134 | ITK | 0.28388198 |
| 135 | AKT2 | 0.26706151 |
| 136 | HIPK2 | 0.25993505 |
| 137 | STK38L | 0.25418134 |
| 138 | CAMKK2 | 0.25277402 |
| 139 | PINK1 | 0.25193862 |
| 140 | FGFR3 | 0.24897509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.28971458 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.78451976 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.76051650 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.50315856 |
| 5 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.40731409 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28587863 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.26676048 |
| 8 | Carbon metabolism_Homo sapiens_hsa01200 | 2.20966081 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.04838601 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95641040 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86400027 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 1.82490785 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.82030857 |
| 14 | Focal adhesion_Homo sapiens_hsa04510 | 1.76957577 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.75672294 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65247272 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64308276 |
| 18 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.62647626 |
| 19 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.56664924 |
| 20 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52459808 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.51798813 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.51317721 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.50280095 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.50244603 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41589316 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.35540934 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32574027 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29978595 |
| 29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28638408 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.23822995 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23136336 |
| 32 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.22746597 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.22309132 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.21331495 |
| 35 | Amoebiasis_Homo sapiens_hsa05146 | 1.20830925 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.18307613 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.18203213 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15317183 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12678352 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10943978 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10860795 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10720252 |
| 43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09359435 |
| 44 | Legionellosis_Homo sapiens_hsa05134 | 1.08597828 |
| 45 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08312696 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.07109495 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.06891134 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 1.05151778 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.04563425 |
| 50 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04163532 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02454606 |
| 52 | Allograft rejection_Homo sapiens_hsa05330 | 1.00857165 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00242206 |
| 54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99415126 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.99308985 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97796992 |
| 57 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96025424 |
| 58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93437442 |
| 59 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93211622 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92747090 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.91012083 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90793072 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90183709 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89470085 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.88757128 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.88552758 |
| 67 | Measles_Homo sapiens_hsa05162 | 0.87900308 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87260611 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87057148 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.87018686 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86038150 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.84908799 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84330273 |
| 74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81963776 |
| 75 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80302369 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.79126433 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78439365 |
| 78 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76125466 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75141858 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.74984979 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.74963894 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.71835512 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.71293085 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.70707253 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69904556 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69710656 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68552124 |
| 88 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68376567 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.67833026 |
| 90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67611489 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66639280 |
| 92 | Tuberculosis_Homo sapiens_hsa05152 | 0.66558853 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64725488 |
| 94 | Salmonella infection_Homo sapiens_hsa05132 | 0.63082540 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61328241 |
| 96 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60656792 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.59619255 |
| 98 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58169444 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57895354 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57886087 |
| 101 | Alzheimers disease_Homo sapiens_hsa05010 | 0.56903373 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.55939021 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55540748 |
| 104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.55340636 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54995142 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53848790 |
| 107 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52810749 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52630935 |
| 109 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52407606 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49941412 |
| 111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48820483 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48688461 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48405265 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.47953934 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46935093 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.46757780 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46465114 |
| 118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46269675 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.46204705 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46176775 |
| 121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.45187051 |
| 122 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.41742170 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41305265 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40385418 |
| 125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.39390683 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38849972 |
| 127 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38222513 |
| 128 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.36185907 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35587497 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.35570277 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34106697 |
| 132 | Tight junction_Homo sapiens_hsa04530 | 0.31494917 |
| 133 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30293560 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29742215 |
| 135 | Protein export_Homo sapiens_hsa03060 | 0.29480568 |

